Carregant...

Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier

Biologics are an emerging class of medicines with substantial promise to treat neurological disorders such as Alzheimer’s disease, stroke and multiple sclerosis. However, the blood-brain barrier (BBB) presents a formidable obstacle that appreciably limits brain uptake and hence, therapeutic potentia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Annu Rev Pharmacol Toxicol
Autors principals: Lajoie, Jason M., Shusta, Eric V.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051266/
https://ncbi.nlm.nih.gov/pubmed/25340933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1146/annurev-pharmtox-010814-124852
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!